Stay updated on Tepotinib & Gefitinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Tepotinib & Gefitinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tepotinib & Gefitinib in NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page displays a new revision label, updating from v3.5.4 to v3.5.5 to reflect a minor update to the study record.
    Difference
    0.0%
    Check dated 2026-06-08T15:30:41.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision tag updated to v3.5.4, replacing the previous v3.5.3, indicating an updated set of study documents on the page. This reflects a documentation revision rather than a change to the study data or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-05-18T03:48:46.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Taoyuan, Taiwan has been added as a site and Taoyuan District, Taiwan has been removed from the study locations. This updates the geographic footprint of the trial sites for INSIGHT.
    Difference
    0.0%
    Check dated 2026-05-03T15:50:51.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page’s footer “Revision” has been updated from v3.5.2 to v3.5.3, indicating a platform/version change rather than a change to the trial’s published information.
    Difference
    0.0%
    Check dated 2026-04-26T15:36:33.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    System revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T13:56:26.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Site revision updated to v3.5.0, replacing the prior v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-21T17:32:11.000Z thumbnail image

Stay in the know with updates to Tepotinib & Gefitinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tepotinib & Gefitinib in NSCLC Clinical Trial page.